• Corpus ID: 46280636

SPECT and PET Amino Acid Tracer Influx via System L ( h 4 F 2 hc-h LAT 1 ) and Its Transstimulation

@inproceedings{Lahoutte2004SPECTAP,
  title={SPECT and PET Amino Acid Tracer Influx via System L ( h 4 F 2 hc-h LAT 1 ) and Its Transstimulation},
  author={Tony Lahoutte and Vicky Caveliers and Simone Camargo and Raffaella Franca and Di Wang Pharm and Tamara Ramadan and Emilija Veljkovic and John Mertens and Axel Bossuyt and François Verrey},
  year={2004}
}
System L amino acid transport is increased in various types of cancer. The tracer 123I-2-iodotyrosine (2IT), which is accumulated via system L, could thus serve to allow visualization of cancer in vivo. Here, we studied the transport of 125I-2IT by h4F2hc-hLAT1, the major transporter subserving system L in growing cells, using the Xenopus laevis oocyte expression system. We compared the apparent affinity of 125I-2IT with that of tyrosine, tested the influence of intracellular methionine… 

Figures from this paper

Correlation of l-methyl-11C-methionine (MET) uptake with l-type amino acid transporter 1 in human gliomas
TLDR
MET SUVmax correlates with LAT1 expression in the tumor in newly diagnosed gliomas, and use of MET-PET as a molecular target combined with anti-angiogenesis in glioma therapy should be addressed in future studies.
2-[18F]FELP, a novel LAT1-specific PET tracer, for the discrimination between glioblastoma, radiation necrosis and inflammation.
TLDR
This study suggests that the 2-[18F]FELP PET is able to differentiate glioblastoma from radiation necrosis and that the two-way uptake is less likely to be contaminated by the presence of inflammation than the [ 18F]FDG signal.
Changes in Tumor Metabolism as Readout for Mammalian Target of Rapamycin Kinase Inhibition by Rapamycin in Glioblastoma
TLDR
Encouraging preclinical data warrant clinical trials evaluating [ 18F]FDG and [18F]FLT-PET for monitoring treatment with mTOR inhibitors in patients, and the effects of rapamycin on glucose and thymidine metabolism could be imaged noninvasively by PET.
Changes in kinetics of amino acid uptake at the ageing ovine blood–cerebrospinal fluid barrier
TLDR
Investigation of kinetics of four AA uptakes at young and old ovine choroid plexus, the blood-cerebrospinal fluid (CSF) barrier (BCB), and measured AA concentrations found the sensitivity and specificity of these transporters were impaired in old BCB.

References

SHOWING 1-10 OF 25 REFERENCES
Tyrosine Membrane Transport in Human L-Type Amino Acid Transporters
TLDR
Investigations on the isoform selectivity of 125 I-IMT transport with 4F2hc-coexpressed Xenopus laevis oocytes found hLAT1 selective, which was more selective than either of the 2 human L-type amino acid transporters.
Increased tumor uptake of 3-(123)I-Iodo-L-alpha-methyltyrosine after preloading with amino acids: an in vivo animal imaging study.
TLDR
The results indicate that the fasted state might not be the optimal metabolic condition to study tumor accumulation of L-transported tracers such as (123)I-3-IMT.
Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo.
TLDR
L-[18F]FET, which is transported by the specific amino acid transport system L, seems to be a potential amino acid tracer for tumor imaging and therapy monitoring with PET.
In vitro characterization of the influx of 3-[125I]iodo-L-alpha-methyltyrosine and 2-[125I]iodo-L-tyrosine into U266 human myeloma cells: evidence for system T transport.
TLDR
The kinetic parameters suggest that elevated plasma levels of aromatic amino acids will reduce (123)I-3-IMT uptake in myeloma patients, and both tracers do not enter protein synthesis significantly.
Transport mechanisms of 3-[123I]iodo-alpha-methyl-L-tyrosine in a human glioma cell line: comparison with [3H]methyl]-L-methionine.
TLDR
Transport of both IMT and 3H-MET depends on the proliferation rate of human glioma cells in vitro and is dominated by BCH-sensitive transport.
Characterization of 3-[125I]iodo-alpha-methyl-L-tyrosine transport via human L-type amino acid transporter 1.
TLDR
The level of efflux mediated by hLAT1 was highly stimulated by extracellularly applied L-Leu, suggesting exchange of [(125)I]IMT and L- Leu via hLat1.
Comparison of fluorotyrosines and methionine uptake in F98 rat gliomas.
TLDR
Comparison of FET and FTyr with MET uptake in F98 rat gliomas demonstrated a significant correlation of tumor to brain ratios and a similar intratumoral tracer distribution pattern.
O-(2-[18F]Fluoroethyl)-L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes
TLDR
Analysis of uptake of FDG, MET and FET in tumour-infiltrated and immunologically stimulated LNs demonstrated typical signs of chronic inflammation in STZ-treated animals and acute inflammatory changes in Con A- treated animals.
Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines.
TLDR
The properties of the hLAT1/h4F2hc complex would support the roles of this transporter in providing cells with essential amino acids for cell growth and cellular responses, and in distributing amino acid-related compounds.
Whole-body tumor imaging using PET and 2-18F-fluoro-L-tyrosine: preliminary evaluation and comparison with 18F-FDG.
TLDR
F-TYR PET is not superior to (18)F-FDG PET for staging patients with NSCLC and lymphomas, and several large lymphoma lesions did not accumulate the tracer.
...
1
2
3
...